Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating teriparatide, vibration, and their combination on bone mass and bone architecture in chronic spinal cord injury; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

Sponsor: Thomas J. Schnitzer | Conditions: Spinal Cord Injury, Bone Loss | Phase 2 | Status: COMPLETED | Results posted: 2017-06-22